CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 32 enrolled
Drug / intervention
nicotine replacement therapy (NRT) +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04045964
NCT04045964Phase 4Completed

Nicotine Patch as an Adjunctive Intervention to Reduce Secondhand Smoke Among NICU Families

The University of Texas Health Science Center, Houston·interventional·Posted Aug 6, 2019·Updated Dec 11, 2024

In Brief

A Phase 4 clinical trial evaluating nicotine replacement therapy (NRT), motivational advice, and 1 other intervention for Environmental Tobacco Smoke and Smoking Cessation. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The purpose of this study was to explore the potential for directly targeting smoking cessation, regardless of motivation level, in a subsample of neonatal intensive care unit (NICU) parents with the ultimate goal of reducing secondhand smoke (SHS) in their homes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedAug 6, 2019
Enrollment StartOct 29, 2017
Primary CompletionJun 28, 2018
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 6.9 years ago

Interventions

nicotine replacement therapy (NRT)drug

Participants were provided with either 2 weeks of 14-mg or 21-mg transdermal nicotine patches for every smoker in the home

motivational advicebehavioral

Received two in-hospital motivational advice sessions by a research associate (RA). The RA adapted session content from a previous tobacco-smoke exposure protocol

Quitline referralbehavioral

Quitline participants received information about tobacco-smoke exposure reduction and a referral to a tobacco Quitline.